Recent advances in understanding inherited deficiencies in immunity to infections

Recent advances in understanding inherited... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/9-243" }, "headline": "Recent advances in understanding inherited deficiencies in immunity to infections", "datePublished": "2020-04-07T16:15:32", "dateModified": "2020-04-07T16:15:32", "author": [ { "@type": "Person", "name": "Gregory M. Constantine" }, { "@type": "Person", "name": "Michail S. Lionakis" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "The immune system is central to our interactions with the world in which we live and importantly dictates our response to potential allergens, toxins, and pathogens to which we are constantly exposed. Understanding the mechanisms that underlie protective host immune responses against microbial pathogens is vital for the development of improved treatment and vaccination strategies against infections. To that end, inherited immunodeficiencies that manifest with susceptibility to bacterial, viral, and/or fungal infections have provided fundamental insights into the indispensable contribution of key immune pathways in host defense against various pathogens. In this mini-review, we summarize the findings from a series of recent publications in which inherited immunodeficiencies have helped illuminate the interplay of human immunity and resistance to infection." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/9-243/v1", "name": "Recent advances in understanding inherited deficiencies in immunity..." } } ] } Home Browse Recent advances in understanding inherited deficiencies in immunity... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Constantine GM and Lionakis MS. Recent advances in understanding inherited deficiencies in immunity to infections [version 1; peer review: 2 approved] . F1000Research 2020, 9 (F1000 Faculty Rev):243 ( https://doi.org/10.12688/f1000research.22036.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Review Recent advances in understanding inherited deficiencies in immunity to infections [version 1; peer review: 2 approved] Gregory M. Constantine https://orcid.org/0000-0001-5379-9475 1 , Michail S. Lionakis 1 Gregory M. Constantine https://orcid.org/0000-0001-5379-9475 1 , Michail S. Lionakis 1 PUBLISHED 07 Apr 2020 Author details Author details 1 Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20814, USA Gregory M. Constantine Roles: Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing Michail S. Lionakis Roles: Conceptualization, Data Curation, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS Abstract The immune system is central to our interactions with the world in which we live and importantly dictates our response to potential allergens, toxins, and pathogens to which we are constantly exposed. Understanding the mechanisms that underlie protective host immune responses against microbial pathogens is vital for the development of improved treatment and vaccination strategies against infections. To that end, inherited immunodeficiencies that manifest with susceptibility to bacterial, viral, and/or fungal infections have provided fundamental insights into the indispensable contribution of key immune pathways in host defense against various pathogens. In this mini-review, we summarize the findings from a series of recent publications in which inherited immunodeficiencies have helped illuminate the interplay of human immunity and resistance to infection. READ ALL READ LESS Keywords immunodeficiency, inherited, monogenic, infection, immunology, infectious disease Corresponding Author(s) Michail S. Lionakis ( [email protected] ) Close Corresponding author: Michail S. Lionakis Competing interests: No competing interests were disclosed. Grant information: This work was supported by the Division of Intramural Research at National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2020 Constantine GM and Lionakis MS. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. How to cite: Constantine GM and Lionakis MS. Recent advances in understanding inherited deficiencies in immunity to infections [version 1; peer review: 2 approved] . F1000Research 2020, 9 (F1000 Faculty Rev):243 ( https://doi.org/10.12688/f1000research.22036.1 ) First published: 07 Apr 2020, 9 (F1000 Faculty Rev):243 ( https://doi.org/10.12688/f1000research.22036.1 ) Latest published: 07 Apr 2020, 9 (F1000 Faculty Rev):243 ( https://doi.org/10.12688/f1000research.22036.1 ) Introduction Insights through the observation and study of primary immunodeficiency disorders (PIDs) provide a unique in vivo lens through which our understanding of human immunology can be advanced. Herein, we discuss recent discoveries that have furthered our collective understanding of the host immune response in protection from the constant environmental threats posed by bacteria, viruses, and fungi. We focus on interleukin (IL)-6 receptor-alpha (IL-6Rα) deficiency and dominant activating Rac family small GTPase 2( RAC2 ) mutations leading to bacterial infection susceptibility, EROS deficiency and its impact on innate immunity, interferon (IFN) regulatory factor 4 (IRF4) haploinsufficiency causing susceptibility to Whipple’s disease (WD), defects in IL-12 receptor subunit beta 2 (IL-12RB2), IL-23 receptor (IL-23R), RAR-related orphan receptor C (RORC), Janus kinase 1 (JAK1), and tyrosine kinase 2 (TYK2) contributing to mycobacterial disease, deficiency in IFNα receptor-1 (IFNAR1), melanoma differentiation associated protein-5 (MDA5), IRF9, or IL-18 binding protein (IL18-BP) and gain-of-function (GOF) mutations in NLR family pyrin domain containing 1 ( NLRP1 ) leading to viral infection susceptibility, and fungal infection susceptibility in the setting of caspase recruitment domain-containing protein 9 (CARD9) deficiency, zinc finger protein 341 (ZNF341) deficiency, and c-Jun N-terminal kinase 1 (JNK1) haploinsufficiency. Recent insights gained from primary immunodeficiency disorders manifesting with bacterial infection susceptibility IL-6 signaling: a critical role in control of bacteria Prompt recognition of bacterial pathogens is paramount in the defense against infection, and, among the mechanisms that initiate the immune cascade, IL-6 plays a central role. As a pleiotropic pro-inflammatory cytokine, IL-6 leads to the initiation of the acute-phase response by driving the recruitment of innate immune cells and pathogen phagocytosis while also promoting adaptive immune responses through mediating B cell survival and maturation, T cell proliferation, and the lineage commitment of T follicular, T H 17, and T H 22 helper cells 1 – 3 . Classical cell-membrane signaling of IL-6 is mediated through a hexameric complex composed of two IL-6 molecules, two IL-6Rα receptors, and two transmembrane glycoprotein 130 (gp130) proteins through which signal transduction is propagated via JAK and signal transducer and activator of transcription (STAT) interactions 4 – 6 . Iatrogenic, acquired, and inherited defects have provided evidence of the consequences of impaired IL-6 signaling through their impact on infection susceptibility. Severe staphylococcal infections have been described in patients treated with the anti-IL-6R monoclonal antibody tocilizumab and in spontaneously acquired autoantibodies against circulating IL-6 7 – 9 . Furthermore, inherited homozygous mutations in IL6ST, encoding the gp130 co-receptor, predispose to recurrent severe staphylococcal and streptococcal infections 10 as well as elevated serum IgE and dental and cranio-skeletal manifestations reminiscent of hyper-IgE syndrome (HIES) caused by dominant-negative mutations in STAT3 11 , 12 . It was not until recently that inherited deficiency in IL-6Rα was identified. Specifically, Spencer et al. reported two patients with severe recurrent infections with defective acute-phase response, elevated IgE, atopic dermatitis, and peripheral eosinophilia caused by pathogenic variants in IL6R 13 . An additional four patients from two unrelated families with IL6R mutations were also reported sharing a similar clinical phenotype with severe bacterial infectious complications caused by Streptococcus pneumoniae , Staphylococcus aureus , Haemophilus influenzae , and Neisseria meningiditis 14 ( Table 1 ). Mechanistically, shared among all of these IL-6 pathway functional defects is absent or delayed production of acute-phase reactants including C-reactive protein, which plays a crucial role in the protection against bacterial pathogens including Streptococci , Klebsiella pneumoniae , and Neisseria meningitidis through opsonization and phagocytosis by macrophages and neutrophils 1 , 15 – 17 . Table 1. Recently described primary immunodeficiencies associated with increased risk of infection Gene/ protein Variant(s) Inheritance model Clinical manifestations Laboratory findings Associated pathogens Host response to bacteria IL6R /IL- 6RA G183Efs*7;I279N AR, LOF Atopic dermatitis, respiratory infections, skin abscesses, recurrent skin infections Variably low IgG, IgA ↑ IgE ↓ CRP Streptococcus pneumoniae , Staphylococcus aureus , Haemophilus influenzae , Neisseria meningitidis IRF4 /IRF4 R98W AD, haploinsufficiency Whipple’s disease, chronic Tropheryma whipplei carriage NR T. whipplei RAC2 /RAC2 E62K; P34H AD, GOF Recurrent sinopulmonary infections, bronchiectasis, cellulitis, lymphadenitis, B cell lymphoma, littoral cell angioma Neutropenia, lymphopenia, variable hypogammaglobulinemia, increased DHR N. meningitidis , varicella zoster, HPV, herpes simplex CYBC1 / EROS c.127G>A; Y2X AR, LOF Short stature, skin/soft tissue infections, lymphadenitis, recurrent sinopulmonary infections, granulomatous inflammation, AIHA, HLH, CGD, IBD Impaired DHR, lymphopenia BCG, Burkholderia cepacia, Legionella, Candida albicans, Clostridium difficile, Mycobacterium tuberculosis Host response to mycobacteria IL12RB2 / IL-12Rβ1 Q138X AR, LOF Lymphadenitis, pulmonary tuberculosis Increased naïve CD4 + and CD8 + T cells BCG, M. tuberculosis IL23R /IL- 23R C115Y AR, LOF Lymphadenitis, disseminated BCG infection Increased naïve CD4 + and CD8 + T cells BCG TYK2/ TYK2 P1104A AR, LOF Primary tuberculosis Increased naïve CD4 + and CD8 + T cells, reduced effector memory T cells M. tuberculosis, NTM RORC /RORγ/ RORγt Q308X; Q420X AR, LOF Thymic hypoplasia, CMC, disseminated BCG infection, tuberculosis, eczematous dermatitis, recurrent skin infections CD4 + and CD8 + T cell lymphopenia ↓IFN-γ production ↓ IL-17A/F, IL-21, IL-22 production BCG, M. tuberculosis, C. albicans JAK1 / JAK1 P733L; P832S AR, LOF Recurrent sinopulmonary infections, osteomyelitis, developmental delay, urothelial carcinoma, skin infections, flat warts, crusted scabies Reduced naive CD4 + and CD8 + T cells, Impaired PHA response Impaired IFN-γ, IFN-α, IL- 2, IL-4, IL-10, and IL-27 responses ↓IFN-γ production ↑ IL-6 production NTM, Sarcoptes scabiei , HPV Host response to viruses IFNAR1 / IFNAR1 V225fs; W261X, V225_P23 2del AR, LOF Disseminated vaccine- strain measles, yellow fever vaccine-associated viscerotropic disease Impaired type I IFN responses Vaccine-strain measles, vaccine-strain yellow fever IFIH1 / MDA5 K365E AR, LOF Recurrent viral respiratory infections Reduced IFN-β, IFN-λ transcription HRV, influenza B, influenza A, coronavirus, RSV, parainfluenza IRF9 /IRF9 E166Lfs*80, D331N AR, LOF Recurrent viral infections, severe influenza infection Variable mild lymphopenia, variable hypogammaglobulinemia, impaired type I IFN responses Influenza A IL18BP /IL- 18 BP c.508-19_528del AR, LOF HAV-induced acute liver failure ↑ IL-18 HAV NLRP1 / NLRP1 T755N AR, GOF Recurrent respiratory papillomatosis, palmar and plantar warts ↑ IL-18 ↑TNF-α HPV TLR3 /TLR3 P554S; P680L AD, LOF Acute respiratory distress syndrome ↓IFN-β and IFN-λ from fibroblasts Influenza A, RSV Host response to fungi CARD9 / CARD9 NA AR, LOF Mucocutaneous and CNS fungal infections ↓ CNS neutrophil recruitment due to impaired IL-1β/CXCL1 microglial production ↓ neutrophil killing against unopsonized Candida yeasts Impaired IL-17 responses C. albicans, Aspergillus species, agents of dermatophytosis and phaeohyphomycosis ZNF341 / ZNF341 R302X; K355fs; Y542X; Q195X AR, LOF CMC, staphylococcal skin infections, respiratory infections, bronchiectasis, severe atopic dermatitis, food and environmental allergy, connective tissue abnormalities Low NK Cells Low memory B cells Low central memory CD4 + and CD8 + T cells Low IgM, IgA ↑ IgE S. aureus, C. albicans, Candida glabrata MAPK8 / JNK1 c.311+1G>A AD, haploinsufficiency Systemic connective tissue disorder, CMC, recurrent bacterial skin infections, urinary tract infections Impaired IL-17A/F responses C. albicans, Staphylococcal species AD, autosomal dominant; AIHA, autoimmune hemolytic anemia; AR, autosomal recessive; BCG, Bacillus Calmette-Guérin; CARD9, caspase recruitment domain-containing protein 9; CGD, chronic granulomatous disease; CMC, chronic mucocutaneus candidiasis; CNS, central nervous system; CRP, C-reactive protein; DHR, dihydrorhodamine test; GOF, gain-of-function; HAV, Hepatitis A virus; HLH, hemophagocytic lymphohistiocytosis; HPV, human papilloma virus; HRV, human rhinovirus; IBD, inflammatory bowel disease; IFN, interferon; IFNAR1, interferon alpha receptor-1; Ig, immunoglobulin; IL, interleukin; IL-6RA, interleukin-6 receptor-alpha; IL-12Rβ1, interleukin-12 receptor subunit beta 1; IL-18 BP, interleukin-18 binding protein; IL-23R, interleukin-23 receptor; IRF, interferon regulatory factor; JAK1, Janus kinase 1; JNK1, c-Jun N-terminal kinase 1; LOF, loss-of-function; MDA5, melanoma differentiation associated protein-5; NA, not applicable; NK, natural killer; NLRP1, NLR family pyrin domain containing 1; NR, not reported; NTM, non-tuberculous mycobacteria; PHA, phytohemagglutinin; RAC2, Rac family small GTPase 2; ROR, RAR-related orphan receptor; RSV, respiratory syncytial virus; TNF, tumor necrosis factor; TLR3, Toll-like receptor-3; ZNF341, zinc finger protein 341. As the IL-6 signaling pathway has been implicated in autoimmune and inflammatory diseases such as rheumatoid arthritis, giant cell arteritis, Castleman’s disease, and cytokine release syndrome in the setting of CAR T cell therapy for malignancies, anti-IL-6R therapies have become increasingly more common 18 . As such, surveillance for bacterial infectious complications is warranted in the setting of anti-IL-6 biological therapies. Whipple’s disease: 111 years later Described initially by George Hoyt Whipple 19 , WD is a chronic infection manifested by malabsorptive diarrhea, weight loss, and arthritis caused by the Gram-positive bacillus Tropheryma whipplei 20 . Despite T. whipplei being ubiquitous in the soil and water, WD is rare, with an estimated incidence of 1–3 cases per 1 million people 21 . Interestingly, asymptomatic carriage is relatively frequent, ranging from ~4–31% depending on the geographical area 22 , 23 . The vast majority of infected individuals suffer from self-limited illness, suggesting that an impaired immunological response may play a role in those with chronic or invasive forms of the disease 24 – 27 . Through the investigation of four related patients with WD, Guérin et al. reported a rare loss-of-function (LOF) mutation in IRF4 causing haploinsufficiency 28 . It is important to note that a total of 12 individuals were found to be heterozygous for the p.R98W variant in IRF4 ( Table 1 ), including the four WD patients, five chronic T. whipplei carriers, two non-carriers, and one relative who was not tested for T. whipplei, thereby indicating incomplete penetrance. IRF4 is an important transcription factor for the development of immune cells as well as T H 2, T H 9, and T H 17 responses ( Figure 1 ); however, its role in the control of bacterial infection has been less clear 29 , 30 . In vitro studies of patient cells demonstrated that the mutant IRF4 allele failed to bind DNA or induce transcription. Additional transcriptional analysis of T. whipplei -infected peripheral blood mononuclear cells (PBMCs) did not detect specific pathway enrichment; however, Mycobacterium bovis –Bacillus Calmette-Guérin (BCG)-infected PBMCs demonstrated downregulation of STAT1 and IFN-γ-associated pathways. These results suggest that IRF4 haploinsufficiency may predispose to T. whipplei via impaired T H 1 helper cell mechanisms. Despite the potential impact on the IFN-γ axis, patients with IRF4 haploinsufficiency appear to be selectively susceptible to WD without susceptibility to other intracellular pathogens that rely on intact IFN-γ/STAT1 signaling (e.g. mycobacteria, Salmonella , etc.), implying that other parallel and/or compensatory immune mechanisms may play a role. Additional work is needed to further delineate the cell-specific mechanistic role of IRF4 in host defense against WD. Figure 1. The IFN-γ/IL-12, IL-23, IL-17 axis and NADPH complex in host defense against pathogens Mycobacteria are recognized and phagocytosed, leading to IL-12 (p40/p35) secretion by macrophages. Binding of IL-12 to its receptor on the surface of T H 1 (or NK) cells activates the downstream JAK2 and TYK2 signaling cascade, resulting in STAT4 phosphorylation and dimerization. STAT4 homodimers translocate to the nucleus and induce the transcription of IFN-γ. Phosphorylated STAT1 homodimers translocate to the nucleus, resulting in the transcription of host defense genes. Similarly, IL-23 comprising the p40 and p19 subunits binds to the IL-23 receptor, leading to JAK2/TYK2 activation and STAT3 phosphorylation, dimerization, and nuclear translocation, where it associates with IRF4 and RORγt in the transcription of IL17 - , IL21 - , and IL22 -related genes. The membrane-bound gp91 phox and p22 phox heterodimer (cytochrome b558) is stabilized by the transmembrane chaperone protein EROS. The remaining cytosolic components, p67 phox , p47 phox , and p40 phox , along with RAC2-GTP, associate to form the activated NADPH complex. Secondary signal from CD40/CD40L signaling activates the NF-κB pathway. GATA2, GATA binding factor 2; gp, glycoprotein; IFN, interferon; IFNG, interferon gamma; IFNGR, interferon gamma receptor; IL, interleukin; IL-12RB, IL-12 receptor subunit beta; IRF4, interferon regulatory factor 4; JAK2, Janus kinase 2; NAPDH, nicotinamide adenine dinucleotide; NEMO, nuclear factor-κB essential modulator; NF-κB, nuclear factor-κB; NK, natural killer; RAC2, Rac family small GTPase 2;RORγt, RAR-related orphan receptor γt; STAT, signal transducer and activator of transcription; T H 1, T helper type 1; TYK2, tyrosine kinase 2. This figure is adapted and amended with permissions, from Figure 3 in Abers, A, Lionakis, M. Chronic mucocutaneous candidiasis and invasive fungal infection susceptibility. In: Sullivan, K.E, Stiehm, E.R Stiehm's Immune Deficiencies-Inborn Errors of Immunit . p1–44. 2nd ed. Copyright Elsevier Science & Technology. 2020 37 . EROS, NADPH oxidase, and innate immunity The generation of reactive oxygen species (ROS) via the nicotinamide adenine dinucleotide (NADPH) complex is an essential component of innate host defense. Mutations in four of the genes encoding the protein components of the NADPH complex (gp91 phox , p22 phox, p67 phox , and p47 phox ) cause chronic granulomatous disease (CGD) manifested by an impaired phagocyte respiratory burst resulting in infectious susceptibility to bacteria and fungi 31 , 32 . Instead, inherited defects affecting the fifth protein, p40 phox , result in severe inflammatory complications with modest infection susceptibility 33 . A newly described transmembrane protein, EROS, has also been identified to play a key role in ROS production through stabilization of the gp91 phox and p22 phox heterodimer, cytochrome 588b 34 ( Figure 1 ). A cohort of eight individuals with a homozygous null mutation in CYBC1 encoding EROS demonstrated a CGD-like disease with severe infections and associated colitis 35 . Patients demonstrated absent cytochrome 588b surface expression and severely reduced neutrophil oxidative burst. Interestingly, Thomas et al . 36 reported a Saudi Arabian boy with biallelic mutations affecting CYBC1 who, unlike the previously reported patients, suffered from recurrent sinopulmonary infections, autoimmune hemolytic anemia, and hemophagocytic lymphohistiocytosis (HLH) ( Table 1 ). Evaluation of the patient’s PBMCs showed absent EROS protein, while neutrophils demonstrated defective respiratory burst following stimulation with either phorbol 12-myristate 13-acetate (PMA) or zymosan. These cases provide additional evidence for EROS deficiency manifesting as a CGD-like disease but, given the heterogeneous clinical phenotype, also raise questions for additional roles that EROS may play in infection susceptibility and inflammation. Dominant activating RAC2 mutations and bacterial lung disease RAC2 is a guanine nucleotide-binding protein belonging to the rho guanosine triphosphatase (GTPase) family. It is expressed in the hematopoietic compartment, where it promotes cell migration, adhesion, and oxygen radical production 38 , 39 ( Figure 1 ). Human RAC2 LOF mutations have been described to result in neutrophil defects 40 , severe combined immunodeficiency 41 , and a common variable immunodeficiency (CVID) clinical phenotype 42 . Recently, RAC2 dominant activating mutations were discovered in which patients suffered from recurrent bacterial sinopulmonary infections and bronchiectasis 43 , 44 . Patients exhibited lymphopenia possibly as a result of increased apoptosis 43 while neutrophils demonstrated excessive superoxide production ( Table 1 ), aberrant n-formyl methionyl-leucyl-phenylalanine (fMLF)-mediated chemotaxis, impaired macropinocytosis, and compromised actin remodeling in vitro 44 . This combined immunodeficiency underscores the importance of both neutrophil and lymphocyte function in the protection against bacterial lung disease. Teasing apart cellular signaling in the host response to mycobacteria IFN-γ is critical for the control of intracellular pathogens including mycobacteria, Salmonella , Listeria, endemic fungi, and others 45 , 46 . Disorders of mendelian susceptibility to mycobacterial disease (MSMD) comprise 11 different genes to date, resulting in 21 different genetic diseases 47 . Of these rare inherited disorders, autosomal-recessive (AR) IL-12 receptor β1 (IL-12Rβ1) deficiency accounts for the majority of cases 48 . The IL12RB1 gene encodes for IL-12Rβ1, which mediates IL-12 and IL-23 signaling via dimerization with IL-12Rβ2 and IL-23R components to form IL-12 and IL-23 receptors, respectively 49 , 50 ( Figure 1 ). Similarly, mutations in IL12B encoding the IL-12 p40 subunit common to both IL-12 and IL-23 exhibit a clinical phenocopy of IL-12Rβ1 deficiency 51 . Unlike most other MSMDs, a subset of patients with either of these two PIDs also carry susceptibility to chronic mucocutaneous candidiasis (CMC), thought to originate from compromised signaling via the IL-23/IL-17 pathway that is important for T H 17 cell development and mucosal immunity 52 . As both IL-12 and IL-23 signaling are impaired by these disorders, the individual contribution of each of these cytokines in the immune response to mycobacteria and mucosal candidiasis had remained unclear. Through the identification of AR LOF mutations in either IL12RB2 or IL23R affecting separate kindreds with MSMD without CMC, Martínez-Barricarte et al . underscored the importance of both IL-12 and IL-23 signaling pathways and their effects on IFN-γ mediated immunity 53 ( Table 1 ). Compared to healthy controls, patients deficient in IL-12Rβ2 demonstrated fewer memory T H 1 cells and impaired T H 1 differentiation in vitro , while IL-23R-deficient patient T cells showed impaired T H 17 differentiation in vitro . The authors further investigated the impact of IL-12 and IL-23 on IFN-γ cellular responses by isolating several lymphoid cell types (i.e. B, CD4 + T, CD8 + T, γδ + T, and natural killer [NK] cells, type-1 innate lymphocyte cells [ILC1s], type-2 ILCs [ILC2s], type-3 ILCs [ILC3s], NKT cells, and mucosal-associated invariant T [MAIT] cells) from healthy donors. In response to IL-12 stimulation, B, T, γδ + , and NK cells and ILC1s and ILC2s produced IFN-γ, whereas only NKT and MAIT cells preferentially produced IFN-γ in response to IL-23. Interestingly, ILC3s produced IFN-γ upon either IL-12 or IL-23 stimulation. Taken together, these recent findings demonstrate the cooperative effect of these cytokines among a panoply of cell types to promote IFN-γ-mediated protection from mycobacterial infection. Like IL-12Rβ1 deficiency, AR TYK2 deficiency demonstrates impaired IFN-γ-mediated immunity through defective IL-12 and IL-23 signaling, resulting in intracellular bacterial (and/or viral) infections 54 , 55 ( Figure 1 ). Recently, a common TYK2 mutation, P1104A, with a homozygous allele frequency of ~1/600 Europeans, has been identified 56 ( Table 1 ). Unlike complete TYK2 deficiency, TYK2 P1104A exclusively impairs IL-23 responses due to compromised catalytic activity, thereby disrupting IFN-γ production and conferring risk of mycobacterial infection 56 . In individuals of European ancestry, TYK2 P1104A may underlie a genetic basis for ~1% of tuberculosis cases; these findings indicate that inherited risk alleles may underpin infection susceptibility at the population level 57 . RORC in the control of mycobacteria and Candida RORC encodes the transcription factors RORγ and RORγt. RORγ is ubiquitously expressed, whereas the RORγt isoform is restricted to lymphocytes where it regulates IL-17-related gene transcription ( Figure 1 ) and T H 17 T cell development 58 , 59 . Recently, biallelic mutations in RORC affecting seven individuals from three unrelated kindreds with CMC and atypical mycobacterial infections have been described 60 . Patient cells demonstrated impaired IL-17A, IL-17F, and IL-22 responses, likely accounting for mucosal susceptibility to Candida albicans. In the evaluation of the etiology of mycobacterial vulnerability, PBMCs exposed to BCG and IL-12 demonstrated reduced IFN-γ secretion as a result of selectively impaired γδ and CCR6 + CXCR3 + CD4+ αβ T cell subsets. These findings show that RORC plays an integral role in both IL-17 and type II IFN pathways. JAK1: a complex immunodeficiency The JAK–STAT pathway is central to many signaling cascades. Of the four JAKs, JAK1 is involved in multiple signaling pathways including IL-2, IL-4, IL-7, IL-9, IL-15, IL-21, and IL-27 as well as the IL-6 and IL-10 families of cytokines 61 . As a result of JAK1’s widespread function, its deletion has been shown to be lethal in mice 62 . To date, only a single patient with partial JAK1 deficiency has been reported ( Table 1 ), resulting in a combined immunodeficiency complicated by atypical mycobacterial osteomyelitis, sinopulmonary and skin infections, flat warts, and severe crusted scabies 63 . Beyond infectious complications, the patient demonstrated developmental delay and an early death as a result of metastatic urothelial cancer at age 23. Functional studies demonstrated impaired JAK–STAT phosphorylation leading to compromised responses to multiple cytokines including IL-2 and type I and type II IFNs. These broad signaling defects are likely responsible for the T cell lymphopenia and viral and mycobacterial susceptibility, respectively. Recent insights gained from primary immunodeficiency disorders manifesting with viral infection susceptibility Novel primary immunodeficiency disorders of defective type I and III interferon signaling Patients with germline defects in antiviral immunity have been shown to suffer from disseminated infection when exposed to live viral vaccine strains 64 . Deficiencies in STAT1 65 , STAT2 66 , 67 , or IFNAR2 68 have been reported to predispose to severe infection from the live-attenuated measles, mumps, and rubella (MMR) vaccination strain. Shared among these disorders are important elements in the host antiviral response as mediated through type I (and type III) IFNs. Type I IFN signaling occurs via binding of the IFNAR, composed of two subunits, IFNAR1 and IFNAR2. IFNAR then activates JAK1 and TYK2, which phosphorylate STAT1 and STAT2. The resulting STAT1/STAT2 heterodimers translocate to the nucleus, where they assemble with IRF9 to form the IFN-stimulated gene factor 3 (ISGF3) complex, leading to the downstream transcription of IFN-stimulated genes (ISGs) responsible for antiviral host defense 69 . In a recent report, Hernandez et al . describe two patients with AR splice defects in IFNAR1 who experienced severe infectious complications following vaccination with MMR and yellow fever vaccine strains, respectively 70 . Patient cells demonstrated lack of IFNAR1 expression, unresponsiveness to type I IFN stimulation ( Table 1 ), and inability to control viral replication of measles and yellow fever viruses in vitro . Novel advances in the understanding of IFN signaling have also been illuminated by the study of three patients with AR LOF IRF9 mutations. A 5-year-old girl manifested severe influenza A virus (IAV) pneumonitis 71 , and a 10-year-old boy suffered from recurrent viral infections resulting in neurological impairment and bronchiectasis. A third patient, the 6-month-old sister of the 10-year-old boy, was healthy at the time of the report, potentially suggestive of incomplete penetrance 72 ( Table 1 ). Patient cells demonstrated normal STAT1 and STAT2 phosphorylation but were unable to form the necessary ISGF3 complex, resulting in impaired induction of ISGs and failure to control viral replication in vitro . Additional genetic evidence of influenza virus susceptibility comes from the recent description of three children with autosomal-dominant (AD) Toll-like receptor-3 (TLR3) deficiency complicated by IAV-induced acute respiratory distress syndrome 73 . TLR3 acts as an intracellular sensor of double-stranded DNA (dsDNA), and its activation stimulates type I and III IFN production 74 ( Table 1 ). Dominant-negative TLR3 mutations were initially recognized to cause defective intrinsic immunity of the central nervous system (CNS), impairing host IFN response to herpes simplex virus-1 (HSV-1) and underlying HSV encephalitis (HSE) in otherwise healthy children 75 . As previously described for dominant-negative TLR3 deficiency 75 , leukocytes from the patients with AD TLR3 deficiency demonstrated normal type I/III IFN activation. However, like patients with IRF9 71 or IRF7 deficiency 76 , fibroblasts and induced pluripotent stem cell-derived pulmonary epithelial cells (iPSC-PECs) failed to control IAV replication. Importantly, the phenotype could be rescued in iPSC-PECs when treated with IFN-α or IFN-λ1, highlighting the importance of intrinsic type I and III IFN immunity for viral control in the lung 73 . In addition to influenza, enteroviruses such as human rhinovirus (HRV) are major causes of respiratory viral infections, particularly in young children and immunocompromised adults 77 . In the induction of protection against these viruses, MDA5 senses long fragments of cytosolic dsDNA, leading to the production of type I IFNs and pro-inflammatory IL-1 family of cytokines 78 , 79 . Several LOF mutations in IFH1 , encoding MDA5, have been reported in patients suffering from severe respiratory viral infections 80 – 82 ( Table 1 ). These mutations impaired downstream IFN signaling and led to defective control of HRV replication in vitro 80 , 81 . Taken together, these data underscore the complex interplay found in host defense against a variety of viral pathogens and the crucial role that type I and III IFN signaling plays in the antiviral response. Novel defects of hyperactive immunity leading to viral infection-related morbidity Recurrent respiratory papillomatosis (RRP) is a rare disease resulting in recurrent benign papillomas of the respiratory mucosa in otherwise healthy children and is typically caused by chronic infection with human papilloma virus (HPV) serotypes 6 or 11 83 . Thus far, an immunologic etiology for this disease has remained unknown. Drutman et al . reported two brothers with juvenile-onset RRP who harbor a private homozygous NLRP1 mutation resulting in a GOF as demonstrated by increased IL-1β secretion and spontaneous inflammasome activation 84 ( Table 1 ). Interestingly, HPV6 or HPV11 was not detected in either patient, presumably because of an exaggerated antiviral response from inflammasome activation and inflammatory cytokine secretion. The cause of papilloma formation remains to be elucidated but may be secondary to the overproduction of inflammatory IL-1 family cytokines resulting in increased keratinocyte growth factor expression-mediated proliferation and papilloma formation 85 , 86 . Less than one percent of children with hepatitis A viral (HAV) infection develop acute liver failure (ALF), and although liver transplantation has significantly improved outcomes, mortality remains greater than 10% 87 – 89 . HAV replication alone does not result in hepatocellular injury; instead, non-HAV-specific “bystander-activated” CD8 + T cells have been implicated in hepatocyte cytotoxicity 90 . The mechanisms remain unclear, but evidence suggests that co-stimulation by type I IFNs and IL-18 results in potent T cell activation and IFN-γ secretion 91 , 92 . IL-18BP is important in the negative regulation of IFN-γ-mediated immune responses by binding IL-18 and preventing interaction with the IL-18 receptor. Belkaya et al . reported a child who succumbed to HAV-induced ALF as a result of AR IL-18BP deficiency, demonstrating that the mutant IL-18BP failed to block IL-18 activity 93 ( Table 1 ). Additionally, they provided important in vitro evidence that IL-18 mediates hepatotoxic effects via NK cell activation and cytotoxicity and that treatment with IL-18BP rescues the phenotype, indicating that recombinant IL-18BP may have therapeutic value in patients with ALF 93 . These reports emphasize the concept that unrestrained immune activation following viral infection may lead to serious clinical ramifications in patients with defects in immunoregulation or persistent inflammatory mediator production. Recent insights gained from PIDs manifesting with fungal infection susceptibility The mechanism of CARD9-dependent protection against central nervous system fungal invasion CARD9 deficiency has been known to result in fungal-specific infection susceptibility with a predilection for mucocutaneous tissues and the CNS 94 , 95 . The CNS-targeted susceptibility to Candida infection was recently elucidated. Specifically, CARD9 deficiency results in impaired recruitment of neutrophils into the Candida -infected CNS in mice and humans. The resultant CNS neutropenia, which is detrimental for control of fungal CNS invasion, is not due to peripheral neutropenia or impaired neutrophil-intrinsic chemotaxis but instead is caused by defective induction of critical pro-inflammatory molecules in the fungal-infected CNS that abrogate neutrophil trafficking from the blood into the CNS 96 . A recent follow-up study by Drummond et al . shed further light onto the cellular and molecular basis of the CNS neutrophil trafficking defect of CARD9 deficiency 97 . Specifically, it was shown that, in response to the fungal peptide toxin Candidalysin, CARD9 is critical in CNS-resident microglia for the production of IL-1β via both transcriptional regulation and inflammasome activation, which in turn activates the production of neutrophil-recruiting CXCL1 by CNS-resident microglia and astrocytes to promote fungal control in the CNS. Taken together, two-step tissue-specific “hits” are operational in CARD9 deficiency; impaired IL-17 responses at the mucosal level allow for Candida translocation into the blood and from there to the CNS, where impaired IL-1β/CXCL1-dependent crosstalk between resident microglia and recruited neutrophils results in CNS fungal persistence. Fungal mucosal immunity and connective tissue disorders CMC is manifested by superficial infections of the skin, nails, and mucous membranes caused by Candida species. As IL-17 is essential for antifungal mucosal immunity, inherited disorders underlying vulnerability to CMC are associated with impaired IL-17 signaling. Indeed, mutations in genes of the IL-17 signaling pathway, namely IL-17RA 98 , IL-17RC 99 , IL-17F 98 , and TRAF3IP2 100 , have been described in humans. Patients with AR AIRE deficiency resulting in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) 101 , 102 carry neutralizing autoantibodies against IL-17F and IL-22 103 , 104 . Other genetic disorders that lead to impaired T H 17 development include dominant-negative STAT3 mutations underlying Job’s syndrome 105 , DOCK8 deficiency 106 , the recently described deficiency in ZNF341 ( Table 1 ), a transcription factor that binds to the STAT3 promoter and results in defective STAT3 transcription and activity 107 , 108 , RORC deficiency 60 , and STAT1 GOF 109 , 110 . In a recent report, Li et al . described a three-generational family with AD CMC and an atypical connective tissue disorder (CTD) due to mitogen-activated protein kinase-8 (MAPK8) haploinsufficiency 111 . MAPK8 encodes JNK1, a central component in the MAPK signaling pathway important in the transduction of cellular responses within many contexts 112 , including transforming growth factor beta (TGF-β) signaling 113 and the IL-17A response pathway downstream of ACT1 100 . Evaluation of patient cells demonstrated reduced activation following IL-17A/F cytokine stimulation, impaired T H 17 differentiation, and reduced proportion of T H 17 cells in vitro 111 . Moreover, patient fibroblasts showed impaired JNK1-mediated phosphorylation of activator protein-1 (AP-1) following TGF-β stimulation. These findings suggest that JNK1 haploinsufficiency results in combined impairment of IL-17 and TGF-β cellular responses, resulting in CMC and CTD. Conclusion Research of PIDs provides an exciting opportunity to advance our understanding of human health. As technology continues to rapidly advance, so too does our sophistication in detecting subtle and once-unrecognized defects in the human immune response. As illustrated in the reviewed works above, certain defects may lend to a narrow range of infectious susceptibly often as a result of redundant host defense mechanisms selected throughout our evolution. Furthermore, with the increased access and availability to molecular sequencing platforms, the number of novel and interesting variants is expected to increase at an exponential rate. Evaluating these coding, non-coding, and epigenetic variants will further our understanding of the function and regulation of the human immune system. Deciphering the intricate interplay of hematopoietic and non-hematopoietic cells, organ-specific immunity, and environmental factors that influence infection susceptibility should help inform improved therapeutic and vaccination strategies in vulnerable patients. Faculty Opinions recommended References 1. Rose-John S, Winthrop K, Calabrese L: The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol. 2017; 13 (7): 399–409. PubMed Abstract | Publisher Full Text 2. Korn T, Bettelli E, Oukka M, et al. : IL-17 and Th17 Cells. Annu Rev Immunol. 2009; 27 : 485–517. PubMed Abstract | Publisher Full Text 3. Hunter CA, Jones SA: IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015; 16 (5): 448–57. PubMed Abstract | Publisher Full Text 4. Boulanger MJ, Chow D, Brevnova EE, et al. : Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science. 2003; 300 (5628): 2101–4. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 5. Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997; 15 : 797–819. PubMed Abstract | Publisher Full Text 6. O’Shea JJ, Plenge R: JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012; 36 (4): 542–50. PubMed Abstract | Publisher Full Text | Free Full Text 7. Nguyen MT, Pødenphant J, Ravn P: Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab. BMJ Case Rep. 2013; 2013 : pii: bcr2012007413. PubMed Abstract | Publisher Full Text | Free Full Text 8. Puel A, Casanova JL: The nature of human IL-6. J Exp Med. 2019; 216 (9): 1969–71. Publisher Full Text 9. Bloomfield M, Parackova Z, Cabelova T, et al. : Anti-IL6 Autoantibodies in an Infant With CRP-Less Septic Shock. Front Immunol. 2019; 10 : 2629. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 10. Schwerd T, Twigg SRF, Aschenbrenner D, et al. : A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med. 2017; 214 (9): 2547–62. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 11. Holland SM, DeLeo FR, Elloumi HZ, et al. : STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007; 357 (16): 1608–19. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 12. Minegishi Y, Saito M, Tsuchiya S, et al. : Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007; 448 (7157): 1058–62. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 13. Spencer S, Köstel Bal S, Egner W, et al. : Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med. 2019; 216 (9): 1986–98. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 14. Nahum A, Sharfe N, Broides A, et al. : Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency. J Allergy Clin Immunol. 2020; 145 (3): 1011–1015.e6. PubMed Abstract | Publisher Full Text 15. Simons JP, Loeffler JM, Al-Shawi R, et al. : C-reactive protein is essential for innate resistance to pneumococcal infection. Immunology. 2014; 142 (3): 414–20. PubMed Abstract | Publisher Full Text | Free Full Text 16. Casey R, Newcombe J, McFadden J, et al. : The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun. 2008; 76 (3): 1298–304. PubMed Abstract | Publisher Full Text | Free Full Text 17. Påhlman LI, Mörgelin M, Kasetty G, et al. : Antimicrobial activity of fibrinogen and fibrinogen-derived peptides--a novel link between coagulation and innate immunity. Thromb Haemost. 2013; 109 (5): 930–9. PubMed Abstract | Publisher Full Text 18. Tanaka T, Narazaki M, Kishimoto T: Interleukin (IL-6) Immunotherapy. Cold Spring Harb Perspect Biol. 2018; 10 (8): pii: a028456. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 19. Whipple GH: A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp. 1907; 18 (198): 382–391. Reference Source 20. Fenollar F, Puéchal X, Raoult D: Whipple’s disease. N Engl J Med. 2007; 356 (1): 55–66. PubMed Abstract | Publisher Full Text 21. Antunes C, Gossman WG: Whipple Disease. In: StatPearls . Treasure Island (FL): StatPearls Publishing; 2017; PubMed Abstract 22. Fenollar F, Trani M, Davoust B, et al. : Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis. 2008; 197 (6): 880–7. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 23. Marth T, Moos V, Müller C, et al. : Tropheryma whipplei infection and Whipple’s disease. Lancet Infect Dis. 2016; 16 (3): e13–22. PubMed Abstract | Publisher Full Text 24. Marth T, Neurath M, Cuccherini BA, et al. : Defects of monocyte interleukin 12 production and humoral immunity in Whipple’s disease. Gastroenterology. 1997; 113 (2): 442–8. PubMed Abstract | Publisher Full Text 25. Kalt A, Schneider T, Ring S, et al. : Decreased levels of interleukin-12p40 in the serum of patients with Whipple’s disease. Int J Colorectal Dis. 2006; 21 (2): 114–20. PubMed Abstract | Publisher Full Text 26. Moos V, Schmidt C, Geelhaar A, et al. : Impaired immune functions of monocytes and macrophages in Whipple’s disease. Gastroenterology. 2010; 138 (1): 210–20. PubMed Abstract | Publisher Full Text 27. Schinnerling K, Moos V, Geelhaar A, et al. : Regulatory T cells in patients with Whipple’s disease. J Immunol. 2011; 187 (8): 4061–7. PubMed Abstract | Publisher Full Text 28. Guérin A, Kerner G, Marr N, et al. : IRF4 haploinsufficiency in a family with Whipple’s disease. eLife. 2018; 7 : pii: e32340. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 29. Nam S, Lim JS: Essential role of interferon regulatory factor 4 (IRF4) in immune cell development. Arch Pharm Res. 2016; 39 (11): 1548–55. PubMed Abstract | Publisher Full Text 30. Biswas PS, Bhagat G, Pernis AB: IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev. 2010; 233 (1): 79–96. PubMed Abstract | Publisher Full Text | Free Full Text 31. Segal BH, Leto TL, Gallin JI, et al. : Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000; 79 (3): 170–200. PubMed Abstract | Publisher Full Text 32. Panday A, Sahoo MK, Osorio D, et al. : NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol. 2015; 12 (1): 5–23. PubMed Abstract | Publisher Full Text | Free Full Text 33. van de Geer A, Nieto-Patlán A, Kuhns DB, et al. : Inherited p40phox deficiency differs from classic chronic granulomatous disease. J Clin Invest. 2018; 128 (9): 3957–3975. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 34. Thomas DC, Clare S, Sowerby JM, et al. : Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 2017; 214 (4): 1111–28. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 35. Arnadottir GA, Norddahl GL, Gudmundsdottir S, et al. : A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease. Nat Commun. 2018; 9 (1): 4447. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 36. Thomas DC, Charbonnier LM, Schejtman A, et al. : EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019; 143 (2): 782–785.e1. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 37. Abers A, Lionakis M: Chronic mucocutaneous candidiasis and invasive fungal infection susceptibility. In: Sullivan, K.E, Stiehm, E.R Stiehm's Immune Deficiencies-Inborn Errors of Immunity. 2nd ed. Elsevier Science & Technology. 2020; 1–44. Reference Source 38. Yang FC, Atkinson SJ, Gu Y, et al. : Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci USA. 2001; 98 (10): 5614–8. PubMed Abstract | Publisher Full Text | Free Full Text 39. Knaus UG, Heyworth PG, Evans T, et al. : Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science. 1991; 254 (5037): 1512–5. PubMed Abstract | Publisher Full Text 40. Ambruso DR, Knall C, Abell AN, et al. : Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. Proc Natl Acad Sci USA. 2000; 97 (9): 4654–9. PubMed Abstract | Publisher Full Text | Free Full Text 41. Accetta D, Syverson G, Bonacci B, et al. : Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol. 2011; 127 (2): 535–538.e1–2. PubMed Abstract | Publisher Full Text 42. Alkhairy OK, Rezaei N, Graham RR, et al. : RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol. 2015; 135 (5): 1380–4.e1–5. PubMed Abstract | Publisher Full Text | Free Full Text 43. Lougaris V, Chou J, Beano A, et al. : A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency. J Allergy Clin Immunol. 2019; 143 (4): 1649–1653.e3. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 44. Hsu AP, Donkó A, Arrington ME, et al. : Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects. Blood. 2019; 133 (18): 1 977–88. PubMed Abstract | Publisher Full Text | Free Full Text 45. MacLennan C, Fieschi C, Lammas DA, et al. : Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis. 2004; 190 (10): 1755–7. PubMed Abstract | Publisher Full Text 46. Roesler J, Kofink B, Wendisch J, et al. : Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol. 1999; 27 (9): 1368–74. PubMed Abstract | Publisher Full Text 47. Rosain J, Kong XF, Martinez-Barricarte R, et al. : Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2019; 97 (4): 360–7. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 48. Bustamante J, Boisson-Dupuis S, Abel L, et al. : Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014; 26 (6): 454–70. PubMed Abstract | Publisher Full Text | Free Full Text 49. Presky DH, Yang H, Minetti LJ, et al. : A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A. 1996; 93 (24): 14002–7. PubMed Abstract | Publisher Full Text | Free Full Text 50. Parham C, Chirica M, Timans J, et al. : A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002; 168 (11): 5699–708. PubMed Abstract | Publisher Full Text 51. Picard C, Fieschi C, Altare F, et al. : Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002; 70 (2): 336–48. PubMed Abstract | Publisher Full Text | Free Full Text 52. Ouederni M, Sanal O, Ikinciogullari A, et al. : Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis. 2014; 58 (2): 204–13. PubMed Abstract | Publisher Full Text | Free Full Text 53. Martínez-Barricarte R, Markle JG, Ma CS, et al. : Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018; 3 (30): pii: eaau6759. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 54. Minegishi Y, Saito M, Morio T, et al. : Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006; 25 (5): 745–55. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 55. Kreins AY, Ciancanelli MJ, Okada S, et al. : Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015; 212 (10): 1641–62. PubMed Abstract | Publisher Full Text | Free Full Text 56. Boisson-Dupuis S, Ramirez-Alejo N, Li Z, et al. : Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018; 3 (30): pii: eaau8714. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 57. Kerner G, Ramirez-Alejo N, Seeleuthner Y, et al. : Homozygosity for TYK2 P1104A underlies tuberculosis in about 1% of patients in a cohort of European ancestry. Proc Natl Acad Sci U S A. 2019; 116 (21): 10430–4. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 58. Yang XO, Pappu BP, Nurieva R, et al. : T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008; 28 (1): 29–39. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 59. Ivanov II, McKenzie BS, Zhou L, et al. : The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell. 2006; 126 (6): 1121–33. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 60. Okada S, Markle JG, Deenick EK, et al. : IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015; 349 (6248): 606–13. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 61. O’Shea JJ, Schwartz DM, Villarino AV, et al. : The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015; 66 : 311–28. PubMed Abstract | Publisher Full Text | Free Full Text 62. Leonard WJ, O’Shea JJ: Jaks and STATs: biological implications. Annu Rev Immunol. 1998; 16 : 293–322. PubMed Abstract | Publisher Full Text 63. Eletto D, Burns SO, Angulo I, et al. : Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection. Nat Commun. 2016; 7 : 13992. PubMed Abstract | Publisher Full Text | Free Full Text 64. Pöyhönen L, Bustamante J, Casanova JL, et al. : Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity. J Clin Immunol. 2019; 39 (4): 376–90. PubMed Abstract | Publisher Full Text 65. Burns C, Cheung A, Stark Z, et al. : A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation-A case report and review of the literature. J Allergy Clin Immunol Pract. 2016; 4 (4): 777–9. PubMed Abstract | Publisher Full Text 66. Hambleton S, Goodbourn S, Young DF, et al. : STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci U S A. 2013; 110 (8): 3053–8. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 67. Moens L, Van Eyck L, Jochmans D, et al. : A novel kindred with inherited STAT2 deficiency and severe viral illness. J Allergy Clin Immunol. 2017; 139 (6): 1995–1997.e9. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 68. Duncan CJ, Mohamad SM, Young DF, et al. : Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med. 2015; 7 (307): 307ra154. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 69. Schreiber G, Piehler J: The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol. 2015; 36 (3): 139–49. PubMed Abstract | Publisher Full Text 70. Hernandez N, Bucciol G, Moens L, et al. : Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J Exp Med. 2019; 216 (9): 2057–70. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 71. Hernandez N, Melki I, Jing H, et al. : Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. J Exp Med. 2018; 215 (10): 2567–85. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 72. Bravo García-Morato M, Calvo Apalategi A, Bravo-Gallego LY, et al. : Impaired control of multiple viral infections in a family with complete IRF9 deficiency. J Allergy Clin Immunol. 2019; 144 (1): 309–312.e10. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 73. Lim HK, Huang SXL, Chen J, et al. : Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019; 216 (9): 2038–56. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 74. Ioannidis I, Ye F, McNally B, et al. : Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol. 2013; 87 (6): 3261–70. PubMed Abstract | Publisher Full Text | Free Full Text 75. Zhang SY, Jouanguy E, Ugolini S, et al. : TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007; 317 (5844): 1522–7. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 76. Ciancanelli MJ, Huang SX, Luthra P, et al. : Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 2015; 348 (6233): 448–53. PubMed Abstract | Publisher Full Text | Free Full Text 77. Walter JM, Wunderink RG: Severe Respiratory Viral Infections: New Evidence and Changing Paradigms. Infect Dis Clin North Am. 2017; 31 (3): 455–74. PubMed Abstract | Publisher Full Text 78. Schoggins JW, Wilson SJ, Panis M, et al. : A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472 (7344): 481–5. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 79. Chow KT, Gale M Jr, Loo YM: RIG-I and Other RNA Sensors in Antiviral Immunity. Annu Rev Immunol. 2018; 36 : 667–94. PubMed Abstract | Publisher Full Text 80. Lamborn IT, Jing H, Zhang Y, et al. : Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J Exp Med. 2017; 214 (7): 1949–72. PubMed Abstract | Publisher Full Text | Free Full Text 81. Asgari S, Schlapbach LJ, Anchisi S, et al. : Severe viral respiratory infections in children with IFIH1 loss-of-function mutations. Proc Natl Acad Sci U S A. 2017; 114 (31): 8342–7. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 82. Zaki M, Thoenes M, Kawalia A, et al. : Recurrent and Prolonged Infections in a Child with a Homozygous IFIH1 Nonsense Mutation. Front Genet. 2017; 8 : 130. PubMed Abstract | Publisher Full Text | Free Full Text 83. Ivancic R, Iqbal H, deSilva B, et al. : Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol. 2018; 3 (1): 22–34. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 84. Drutman SB, Haerynck F, Zhong FL, et al. : Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis. Proc Natl Acad Sci U S A. 2019; 116 (38): 19055–63. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 85. Maas-Szabowski N, Stark HJ, Fusenig NE: Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol. 2000; 114 (6): 1075–84. PubMed Abstract | Publisher Full Text 86. Zhong FL, Mamaï O, Sborgi L, et al. : Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation. Cell. 2016; 167 (1): 187–202.e17. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 87. Moreira-Silva SF, Frauches DO, Almeida AL, et al. : Acute liver failure in children: observations in Vitória, Espírito Santo State, Brazil. Rev Soc Bras Med Trop. 2002; 35 (5): 483–6. PubMed Abstract | Publisher Full Text 88. Squires RH Jr, Shneider BL, Bucuvalas J, et al. : Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006; 148 (5): 652–8. PubMed Abstract | Publisher Full Text | Free Full Text 89. Ng VL, Li R, Loomes KM, et al. : Outcomes of Children With and Without Hepatic Encephalopathy From the Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr. 2016; 63 (3): 357–64. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 90. Kim J, Chang DY, Lee HW, et al. : Innate-like Cytotoxic Function of Bystander-Activated CD8+ T Cells Is Associated with Liver Injury in Acute Hepatitis A. Immunity. 2018; 48 (1): 161–173.e5. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 91. Freeman BE, Hammarlund E, Raué HP, et al. : Regulation of innate CD8 + T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012; 109 (25): 9971–6. PubMed Abstract | Publisher Full Text | Free Full Text 92. Kim TS, Shin EC: The activation of bystander CD8 + T cells and their roles in viral infection. Exp Mol Med. 2019; 51 (12): 1–9. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 93. Belkaya S, Michailidis E, Korol CB, et al. : Inherited IL-18BP deficiency in human fulminant viral hepatitis. J Exp Med. 2019; 216 (8): 1777–90. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 94. Corvilain E, Casanova JL, Puel A: Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults. J Clin Immunol. 2018; 38 (6): 656–93. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 95. Drummond RA, Franco LM, Lionakis MS: Human CARD9: A Critical Molecule of Fungal Immune Surveillance. Front Immunol. 2018; 9 : 1836. PubMed Abstract | Publisher Full Text | Free Full Text 96. Drummond RA, Collar AL, Swamydas M, et al. : CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System. PLoS Pathog. 2015; 11 (12): e1005293. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 97. Drummond RA, Swamydas M, Oikonomou V, et al. : CARD9 + microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment. Nat Immunol. 2019; 20 (5): 559–70. PubMed Abstract | Publisher Full Text | Free Full Text 98. Puel A, Cypowyj S, Bustamante J, et al. : Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011; 332 (6025): 65–8. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 99. Ling Y, Cypowyj S, Aytekin C, et al. : Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015; 212 (5): 619–31. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 100. Boisson B, Wang C, Pedergnana V, et al. : An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013; 39 (4): 676–86. PubMed Abstract | Publisher Full Text | Free Full Text 101. Constantine GM, Lionakis MS: Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev. 2019; 287 (1): 103–20. PubMed Abstract | Publisher Full Text | Free Full Text 102. Ferre EMN, Rose SR, Rosenzweig SD, et al. : Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016; 1 (13): pii: e88782. PubMed Abstract | Publisher Full Text | Free Full Text 103. Kisand K, Bøe Wolff AS, Podkrajsek KT, et al. : Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010; 207 (2): 299–308. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 104. Puel A, Döffinger R, Natividad A, et al. : Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010; 207 (2): 291–7. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 105. Milner JD, Brenchley JM, Laurence A, et al. : Impaired T( H )17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008; 452 (7188): 773–6. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 106. Tangye SG, Pillay B, Randall KL, et al. : Dedicator of cytokinesis 8-deficient CD4 + T cells are biased to a T H 2 effector fate at the expense of T H 1 and T H 17 cells. J Allergy Clin Immunol. 2017; 139 (3): 933–49. PubMed Abstract | Publisher Full Text 107. Frey-Jakobs S, Hartberger JM, Fliegauf M, et al. : ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018; 3 (24): pii: eaat4941. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 108. Béziat V, Li J, Lin JX, et al. : A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018; 3 (24): pii: eaat4956. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 109. van de Veerdonk FL, Plantinga TS, Hoischen A, et al. : STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011; 365 (1): 54–61. PubMed Abstract | Publisher Full Text | Faculty Opinions Recommendation 110. Liu L, Okada S, Kong XF, et al. : Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011; 208 (8): 1635–48. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 111. Li J, Ritelli M, Ma CS, et al. : Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β. Sci Immunol. 2019; 4 (41): pii: eaax7965. PubMed Abstract | Publisher Full Text | Free Full Text | Faculty Opinions Recommendation 112. Zhang W, Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002; 12 (1): 9–18. PubMed Abstract | Publisher Full Text 113. Zhang YE: Non-Smad Signaling Pathways of the TGF-β Family. Cold Spring Harb Perspect Biol. 2017; 9 (2): pii: a022129. PubMed Abstract | Publisher Full Text | Free Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 07 Apr 2020 ADD YOUR COMMENT Comment Author details Author details 1 Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20814, USA Gregory M. Constantine Roles: Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing Michail S. Lionakis Roles: Conceptualization, Data Curation, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information This work was supported by the Division of Intramural Research at National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (1) version 1 Published: 07 Apr 2020, 9:243 https://doi.org/10.12688/f1000research.22036.1 Copyright © 2020 Constantine GM and Lionakis MS. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The author(s) is/are employees of the US Government and therefore domestic copyright protection in USA does not apply to this work. The work may be protected under the copyright laws of other jurisdictions when used in those jurisdictions. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Constantine GM and Lionakis MS. Recent advances in understanding inherited deficiencies in immunity to infections [version 1; peer review: 2 approved] . F1000Research 2020, 9 (F1000 Faculty Rev):243 ( https://doi.org/10.12688/f1000research.22036.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Editorial Note on the Review Process Faculty Reviews are review articles written by the prestigious Members of Faculty Opinions . The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations. Reviewers who approved this article James Verbsky , Division of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, USA Competing interests: No competing interests were declared. (for version 1) David M. Lowe , Institute of Immunity and Transplantation, University College London, UK Competing interests: No competing interests were declared. (for version 1) Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 07 Apr 2020 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 1 07 Apr 20 Faculty Reviews are review articles written by the prestigious Members of Faculty Opinions . The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations. James Verbsky , Division of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, USA Competing interests: No competing interests were declared. View more View less David M. Lowe , Institute of Immunity and Transplantation, University College London, UK Competing interests: No competing interests were declared. View more View less Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Recent advances in understanding inherited...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-243/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-243/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-243/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Constantine GM and Lionakis MS'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-243/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/9-243", templates : { twitter : "Recent advances in understanding inherited deficiencies in immunity.... Constantine GM and Lionakis MS, published by " + "@F1000Research" + ", https://f1000research.com/articles/9-243/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/22036/24302") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "24302"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "61041": 0, "61042": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "e9a2ab36-b3cc-41e0-8c32-688ea054e245"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });